Literature DB >> 17674117

Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases.

K Tanaka1, A Sato, K Kasuga, M Kanazawa, K Yanagawa, M Umeda, M Tada, M Tanaka, M Nishizawa.   

Abstract

We report the four patients with chronic myositis characterized by a very slow progression with cardiomyopathy and frequently with marked respiratory muscle weakness associated with other organ-specific autoimmune diseases such as primary biliary cirrhosis. The histopathology of the muscle showed many degenerative and regenerative fibers, but inflammatory-cell infiltration were minimal. The patients showed favorable response to high-dose corticosteroid treatment. Because of these clinical features, these patients are sometimes misdiagnosed as muscular dystrophy and not treated properly. It is important to distinguish this type of treatable myositis.

Entities:  

Mesh:

Year:  2007        PMID: 17674117     DOI: 10.1007/s10067-007-0698-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

Review 3.  Inclusion body myositis and myopathies.

Authors:  R C Griggs; V Askanas; S DiMauro; A Engel; G Karpati; J R Mendell; L P Rowland
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

4.  Primary biliary cirrhosis and myopathy: an uncommon association.

Authors:  B C Migueletto; A E Neto; E Z Domingues; P P Neves de Castro; H Stocker; S K Marie; L P Meireles; M H Arai
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1999 Sep-Oct

Review 5.  [Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis].

Authors:  K Matsui; Y Aizawa; K Inoue; H Yaguchi; G Toda
Journal:  Rinsho Shinkeigaku       Date:  2000-07

6.  Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and antimitochondrial antibodies.

Authors:  J Varga; T Heiman-Patterson; S Muñoz; L A Love
Journal:  Arthritis Rheum       Date:  1993-10

Review 7.  Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.

Authors:  Marinos C Dalakas
Journal:  Curr Opin Neurol       Date:  2004-10       Impact factor: 5.710

  7 in total
  5 in total

1.  Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Authors:  Jemima Albayda; Aamna Khan; Livia Casciola-Rosen; Andrea M Corse; Julie J Paik; Lisa Christopher-Stine
Journal:  Semin Arthritis Rheum       Date:  2017-06-13       Impact factor: 5.532

2.  Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.

Authors:  Maki Tateyama; Kazuo Fujihara; Tatsuro Misu; Akira Arai; Tomohiro Kaneta; Masashi Aoki
Journal:  BMJ Open       Date:  2015-01-12       Impact factor: 2.692

3.  Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.

Authors:  Sainan Bian; Hua Chen; Li Wang; Yunyun Fei; Yunjiao Yang; Linyi Peng; Yongzhe Li; Fengchun Zhang
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

4.  Cardiac involvement with anti-mitochondrial antibody-positive myositis mimicking cardiac sarcoidosis.

Authors:  Takahide Kadosaka; Shingo Tsujinaga; Hiroyuki Iwano; Kiwamu Kamiya; Azusa Nagai; Yoshifumi Mizuguchi; Ko Motoi; Kazunori Omote; Toshiyuki Nagai; Ichiro Yabe; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2020-09-11

5.  Antimitochondrial Antibody-associated Myopathy with Slowly Progressive Cardiac Dysfunction.

Authors:  Fumihiko Takahashi; Jun Sawada; Akiho Minoshima; Naka Sakamoto; Toshiyuki Ono; Kazumi Akasaka; Hidehiro Takei; Ichizo Nishino; Naoyuki Hasebe
Journal:  Intern Med       Date:  2020-10-28       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.